Open AccessClinical efficacy of Vortioxetine and escitalopram in the treatment of depression
Author(s) -
Shichuan Shao,
Baomin Sun,
Huiqing Sun
Publication year - 2022
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.38.5.5230
Subject(s) - medicine , escitalopram , hamd , vortioxetine , depression (economics) , hamilton depression scale , clinical efficacy , incidence (geometry) , adverse effect , treatment and control groups , major depressive disorder , psychiatry , significant difference , antidepressant , cognition , physics , macroeconomics , optics , economics , hippocampus
This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom